Children hospitalized for COVID-19 during the first winter of the pandemic in Buenos Aires, Argentina

INTRODUCTION

Despite the COVID-19 pandemic has caused hundreds of thousands of deaths worldwide, the information available to date shows that the disease is less severe in the pediatric population [1,2].

Also, there are reports that seem to show that the development of the pandemic may be influenced by the characteristics of each country, its health systems and how they faced the pandemic [3,4].

In addition to the characteristics of its own population and health system, Argentina faced the pandemic in a particular way, including the longest lockdown [5] and mandatory hospitalization of affected infants, regardless of its severity [6]. These characteristics could give a distinctive feature to children hospitalized for this disease.

We aimed to describe the characteristics of patients hospitalized for COVID-19 in a pediatric tertiary hospital in the City of Buenos Aires.

METHODS

Retrospective study, including all patients hospitalized for COVID-19 at the tertiary pediatric hospital in Buenos Aires, Argentina,from April 26 to October 31, 2020. Besides patients admitted for COVID-19, all cases which require hospitalization for other reasons were also tested. The diagnosis was made by identification of SARS-CoV-2 in nasopharyngeal secretions by RT-PCR.

In all cases, sex, age, place of residence (including whether they lived in a poor neighborhood [7]), time of symptoms onset on admission, close contact with a confirmed COVID-19 case, presence of comorbidity and length of hospitalization was registered.

Severity was assessed as described by Dong [8]; patients presenting with SARS-CoV-2- related multisystemic inflammatory syndrome (MIS-C) were considered severe/critical.

Lab tests were also recorded (hemoglobin, differential WBC count, platelets, C-reactive protein, and erythrocyte sedimentation rate).

RESULTS

In the studied period, 578 children and adolescents were hospitalized for COVID-19. Some characteristics of 191 of these patients were mentioned in a preliminary report in the beginning of the pandemic [9]. Here we describe all patients hospitalized for COVID during the whole cold season (May-October), including laboratory data.

The number of hospitalizations per week ranged between 2 and 42 (Median= 30.5; IQR= 21.7-35.7) (Fig. 1).

• Download figure
• Open in new tab

Figure 1. Pediatric hospitalizations for COVID-19, according to epidemiological week

The median age was 4.2 (IQR: 0.7-11.2) years and 54.5% were male. Sixty-seven percent (67.3%) had their residence within the jurisdiction of the hospital (City of Buenos Aires) and, of them, 23.1% lived in a poor neighborhood.

Eighty-three percent (83%) had a history of close contact with a confirmed COVID-19 case. The time of symptoms onset before admission was 1 day (IQR: 1-3). Thirty-five percent (35.3%) had a previous or concomitant diagnosis of other disease, asthma being the most frequent (n = 49) (Table 1).

Disease severity was assessed and 30.8% were considered asymptomatic, 60.4% mild, 7.4% moderate, and 1.4% severe. From the six severe cases, only one required assisted ventilation, and two presented with SARS-CoV-2-related multisystemic inflammatory syndrome (MIS-C). Other six MIS-C cases were admitted to the hospital but SARS-CoV-2 testing was negative at that moment.

The most frequent initial symptom was fever, followed by sore throat and cough (Table 2). Regarding the lab tests, we found that 9.4% showed lymphopenia (lymphocyte differential count <20%) and 23.8% elevated C-reactive protein values (C-reactive protein > 10 mg/dl) (being 100% among severe cases and 10% among asymptomatics)(Table 3).

The length of stay had a median of 6 days (IQR: 2.2-9).

At the time of this report, only one patient with COVID 19 died, due to causes other than the disease, since he was in end-of-life care. All patients were discharged without complications (with phone follow-up), except those whose comorbidity prevented it.

DISCUSSION

Our study strengthens the idea that COVID 19 in pediatrics is, in general, mild. It also supports some characteristics of the disease in Argentina that our early report has suggested [9].

Although it is possible that the age structure (Argentina has twice the number of children under 15 years of age than Italy) and the social behaviour of the different populations influence the differences observed [10] [11], the way in which local health authorities dealt with the pandemic have generated some particular features in our patients: Buenos Aires reported more pediatric cases than other countries, and we found a higher proportion of asymptomatic and mild among those hospitalized.

The City of Buenos Aires, adopted a “test and trace” policy. This program was carried out more strongly in poor neighborhoods, which have a younger population [12]. Mandatory hospitalization was also established for infants, still asymptomatic [6] [13]. Furthermore, those asymptomatic children and adolescents who did not have home conditions to comply with out-of-hospital isolation, were hospitalized for the isolation period [14].

In the period covered by this report (until 10/31/2020) the City of Buenos Aires reported 147,363 cases, of which 12.1% were children and adolescents [15], a substantially higher proportion than that initially reported in China (2.1 %) [16] and Italy [17], but closer to that lately reported in the USA (9%) [18].

We found a high proportion of asymptomatic patients (30.8%), higher than that reported by Götzinger in Europe in 582 children with SARS-CoV-2 infection (16%) [19], probably related to the above mentioned test and trace and institutional isolation policies adopted by the local health authorities. Despite this high number of asymptomatic children, the proportion of those with co-morbidity (35,3%) was similar to other series [20][21]. We only found 5.6% moderate and 1.2% severe cases. Dong et al. in China reported 5.9% severe and critical cases [8] and Tagarro in Spain reports that 9.7% of the cases in his series were severe [22]. Although a report from the United States showed that 32% of hospitalized pediatric patients with COVID-19 were admitted to a PICU, the limited average length of stay (2 days) and the limited proportion of subjects who required assisted ventilation (5.8%) suggests that the admission criteria in this series were broader [21].

Regarding the cases of MIS-C (COVID-19 associated Multisystem Inflammatory Syndrome in Children) that we report, they presented 4 to 6 weeks after reaching a significant number of cases in our city, a moment described as usual for the development of this complication [23]. Finally, we have found that 83% of our patients had close contact with infected people, supporting the idea that children are usually infected from adults [24].

This study has the limitation of presenting data from a single center, although it is probably the public institution that has hospitalized the most pediatric patients with COVID-19 in our country. Moreover, including data for a single center shows that, in a winter with no RSV related hospitalizations, the number of patients hospitalized for COVID-19 is roughly the same number we admit for RSV disease each year [25], whether this is related to non-pharmaceutical interventions used to control the pandemia or not [26].

CONCLUSION

In this study we report 578 cases of children and adolescents hospitalized for COVID-19 in Argentina. Most presented their disease as mild or asymptomatic, supporting the idea that the management of pediatric COVID-19 patients represents more an organizational challenge rather than any one specific clinical task [27].